BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Federal Trade Commission
Merck
Novartis
Daiichi Sankyo
Cipla
Colorcon
Moodys
Fish and Richardson
Johnson and Johnson

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: RE39128

« Back to Dashboard

Summary for Patent: RE39128
Title:Pleuromutilin derivatives as antimicrobials
Abstract:The present invention relates to pleuromutilin derivatives, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medical therapy, particularly antibacterial therapy.
Inventor(s): Berry; Valerie Joan (San Diego, CA), Dabbs; Steven (Harlow, GB), Frydrych; Colin Henry (Sawbridgeworth, GB), Hunt; Eric (Great Dunmow, GB), Sanderson; Francis Dominic (Harlow, GB), Woodnutt; Gary (San Diego, CA)
Assignee: SmithKline Beecham p.l.c. (Brentford, GB)
Application Number:10/631,707
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Use; Dosage form;

Drugs Protected by US Patent RE39128

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: RE39128

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9722817Oct 29, 1997
United Kingdom9813689Jun 25, 1998
PCT Information
PCT FiledOctober 27, 1998PCT Application Number:PCT/GB98/03211
PCT Publication Date:May 06, 1999PCT Publication Number: WO99/21855

International Patents Family Members for US Patent RE39128

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2307551 ➤ Subscribe
China 1283197 ➤ Subscribe
China 1205211 ➤ Subscribe
Colombia 5021129 ➤ Subscribe
Cyprus 1112062 ➤ Subscribe
Czech Republic 20001551 ➤ Subscribe
Czech Republic 298543 ➤ Subscribe
Germany 69826704 ➤ Subscribe
Germany 122007000076 ➤ Subscribe
Denmark 1028961 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Novartis
Merck
Medtronic
Dow
McKinsey
Fish and Richardson
Chubb
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot